Property:Outcome timeline
This is a property of type Text.
V
T0: Baseline one week before radiation
T1: 1 week after start of radiation
T2: 2 weeks after start of radiation
T3: 3 weeks after start of radiation
T4: 4 weeks after start of radiation
T5: 5 weeks after start of radiation (=end of radiation) +
Vitale et al. (2020): ZeOxaNMulti Trial: A Randomized, Double-Blinded, Placebo-Controlled Trial of Oral PMA-Zeolite to Prevent Chemotherapy-Induced Side Effects, in Particular, Peripheral Neuropathy +
T0: Baseline
T1: after 3 months of chemotherapy
T2: after 6 months of chemotherapy +
W
Walsh et al. (2010): Use of alpha,25-dihydroxyvitamin D3 treatment to stimulate immune infiltration into head and neck squamous cell carcinoma +
NI +
Watanabe et al. (2010): Polaprezinc prevents oral mucositis associated with radiochemotherapy in patients with head and neck cancer +
Weekly observartions +
Williams et al. (1996): Phase III double-blind evaluation of an aloe vera gel as a prophylactic agent for radiation-induced skin toxicity +
? +
Wrbka et al. (1987): Unterstützung der Chemotherapie inoperabler Karzinome durch proteolytische Fermente +
T0: Baseline
T1: On average 2 weeks (1-4 weeks) +
Wyatt et al. (2012): Health-Related Quality-of-Life Outcomes: A Reflexology Trial With Patients With Advanced-Stage Breast Cancer +
Before randomization:
T1: 1 week after the last intervention;
T2: 6 weeks after the last intervention +
Wyatt et al. (2017): A Randomized Clinical Trial of Caregiver-Delivered Reflexology for Symptom Management During Breast Cancer Treatment +
T0 = Baseline
T1 = week 1;
T2: week 2;
T3: week 3;
T4: week 4 +
Y
Yap et al. (2017): Predictors of hand-foot syndrome and pyridoxine for prevention of capecitabine-induced hand-foot syndrome: a randomized clinical trial +
Baseline
Start of the 2nd, 4th, 5th, 8th cycle + end of study +
Z
Zalat et al. (2020): Evaluation of the cardioprotective effects of l-carnitine and silymarin in cancer patients receiving anthracycline-containing chemotherapy +
T0: Baseline
T1: after 6 months of chemotherapy +
Zick et al. (2008): Phase II trial of encapsulated ginger as a treatment for chemotherapy-induced nausea and vomiting +
T0: Baseline
T1: After 1 hour of completion of chemotherapy
T2: 3 days after the end of their chemotherapy treatment +
Ö